José Bauermeister, Willey Lin, Ryan Tingler, Albert Liu, Suwat Chariyalertsak, Craig Hoesley, Pedro Gonzales, Ken Ho, Noel Kayange, Thesla Palanee Phillips, Sherri Johnson, Elizabeth Brown, Jillian Zemanek, Cindy E Jacobson, Gustavo F Doncel, Jeanna Piper
INTRODUCTION: End-user perspectives are vital to the design of new biomedical HIV prevention products. Conjoint analysis can support the integration of end-user perspectives by examining their preferences of potential pre-exposure prophylaxis (PrEP) products. The Microbicides Trial Network (MTN) 035 protocol examined three placebo rectal dosage forms (insert, enema and suppository) that could deliver PrEP prior to receptive anal sex (RAS). METHODS: Between April 2019 and July 2020, we enrolled 217 HIV-negative, cisgender men who have sex with men (MSM; n = 172; 79...
March 2024: Journal of the International AIDS Society